History and future of hepatitis B virus control in South Korea - PubMed (original) (raw)

History and future of hepatitis B virus control in South Korea

Do Young Kim. Clin Mol Hepatol. 2021 Oct.

Erratum in

• Erratum to 'History and future of hepatitis B virus control in South Korea' [Clin Mol Hepatol 2021;27:620-622].
  Kim DY. Kim DY. Clin Mol Hepatol. 2022 Oct;28(4):939. doi: 10.3350/cmh.2021.0277.e1. Epub 2022 Jun 24. Clin Mol Hepatol. 2022. PMID: 35748100 Free PMC article. No abstract available.

No abstract available

Keywords: Hepatitis B virus; Korea; Vaccination.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

The author has no conflicts to disclose.

Figures

References

1. 1. Sarin SK, Kumar M, Eslam M, George J, Al Mahtab M, Akbar SMF, et al. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology commission. Lancet Gastroenterol Hepatol. 2020;5:167–228. - PMC - PubMed
2. 1. Yoon JH, Cho SH, Kim DY, Yu SJ, Han KH. Epidemiological and clinical history of viral hepatitis in Korea. Infect Chemother. 2021;53:159–165. - PMC - PubMed
3. 1. Yim SY, Kim JH. The epidemiology of hepatitis B virus infection in Korea. Korean J Intern Med. 2019;34:945–953. - PMC - PubMed
4. 1. Jeong S, Cho Y, Park SM, Kim W. Differential effectiveness of tenofovir and entecavir for prophylaxis of hepatocellular carcinoma in chronic hepatitis B patients depending on coexisting cirrhosis and prior exposure to antiviral therapy: a systematic review and meta-analysis. J Clin Gastroenterol. 2021;55:e77–e86. - PubMed
5. 1. Baik D, Kim BW, Oh JK, Kim KA, Ki M. Costs of viral hepatitis B in the Republic of Korea, 2002-2015. J Viral Hepat. 2020;27:156–167. - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • M2PI
  • PubMed Central

• Medical

  • MedlinePlus Health Information